BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17124954)

  • 1. [Avascular osteonecrosis of the jaws induced by diphosphonates].
    Lannoy D; Decaudin B; Barrier F; Bemba M; Wierre L; Pignon JM; Horrent S; Résibois JP; Wetterwald M; Odou P
    Therapie; 2006; 61(4):363-5. PubMed ID: 17124954
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
    Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'Arco A; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S; Baccarani M; Cavo M
    Blood; 2006 Dec; 108(12):3951-2. PubMed ID: 17114572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteonecrosis associated with the use of biphosphonates: Case report].
    Anguita C T; Agurto P J; Roa E I; Laissle C G
    Rev Med Chil; 2006 Sep; 134(9):1161-5. PubMed ID: 17171218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M; Pogłód R; Maj S; Owczarska K
    Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].
    Neumann B; Gregersen H
    Ugeskr Laeger; 2006 May; 168(21):2078-9. PubMed ID: 16768928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw.
    Sari E; Bulut N; Altundag K
    J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonates and osteonecrosis of the jaw: a case report.
    Reiriz AB; De Zorzi Pde M; Lovat CP
    Clinics (Sao Paulo); 2008 Apr; 63(2):281-4. PubMed ID: 18438586
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
    Gibbs SD; O'Grady J; Seymour JF; Prince HM
    Med J Aust; 2005 Nov; 183(10):549-50. PubMed ID: 16296983
    [No Abstract]   [Full Text] [Related]  

  • 9. More about osteonecrosis.
    Finkelman RD; Clemons M; Bouganim N
    J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern.
    Aguiar Bujanda D; Cabrera Suárez MA; Bohn Sarmiento U; Quintero Pérez S; Aguiar Morales J
    Clin Transl Oncol; 2006 Dec; 8(12):919-21. PubMed ID: 17169767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
    Junquera L; Gallego L
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid].
    Calvo-Villas JM; Tapia Torres M; Govantes Rodríguez J; Carreter de Granda E; Sicilia Guillén F
    Med Clin (Barc); 2006 Oct; 127(15):576-9. PubMed ID: 17153267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management.
    Wong YK; Cheng JC
    Quintessence Int; 2008 Mar; 39(3):195-201. PubMed ID: 18618033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
    Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
    J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports.
    Sarathy AP; Bourgeois SL; Goodell GG
    J Endod; 2005 Oct; 31(10):759-63. PubMed ID: 16186759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report.
    Suleman YF; Meer S; Lurie R
    Head Neck Pathol; 2007 Dec; 1(2):156-64. PubMed ID: 20614268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
    Marx RE
    J Oral Maxillofac Surg; 2003 Sep; 61(9):1115-7. PubMed ID: 12966493
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug induced osteonecrosis of the jaws.
    Weeda LW
    J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.